- Home
- ATYR vs MVIS Comparison
ATYR vs MVIS Comparison
Compare ATYR & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MVIS
- Stock Information
- Founded
- ATYR 2005
- MVIS 1993
- Country
- ATYR United States
- MVIS United States
- Employees
- ATYR N/A
- MVIS N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MVIS Industrial Machinery/Components
- Sector
- ATYR Health Care
- MVIS Technology
- Exchange
- ATYR Nasdaq
- MVIS Nasdaq
- Market Cap
- ATYR 327.0M
- MVIS 308.8M
- IPO Year
- ATYR 2015
- MVIS 1996
- Fundamental
- Price
- ATYR $3.50
- MVIS $1.54
- Analyst Decision
- ATYR Strong Buy
- MVIS Buy
- Analyst Count
- ATYR 6
- MVIS 4
- Target Price
- ATYR $18.60
- MVIS $2.67
- AVG Volume (30 Days)
- ATYR 1.7M
- MVIS 5.2M
- Earning Date
- ATYR 03-13-2025
- MVIS 05-08-2025
- Dividend Yield
- ATYR N/A
- MVIS N/A
- EPS Growth
- ATYR N/A
- MVIS N/A
- EPS
- ATYR N/A
- MVIS N/A
- Revenue
- ATYR $235,000.00
- MVIS $8,147,000.00
- Revenue This Year
- ATYR $1,387.23
- MVIS N/A
- Revenue Next Year
- ATYR $873.22
- MVIS $330.45
- P/E Ratio
- ATYR N/A
- MVIS N/A
- Revenue Growth
- ATYR N/A
- MVIS 277.52
- 52 Week Low
- ATYR $1.42
- MVIS $0.80
- 52 Week High
- ATYR $4.66
- MVIS $1.95
- Technical
- Relative Strength Index (RSI)
- ATYR 49.19
- MVIS 57.24
- Support Level
- ATYR $3.63
- MVIS $1.23
- Resistance Level
- ATYR $3.94
- MVIS $1.69
- Average True Range (ATR)
- ATYR 0.33
- MVIS 0.12
- MACD
- ATYR 0.01
- MVIS 0.05
- Stochastic Oscillator
- ATYR 50.53
- MVIS 75.39
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.